237 related articles for article (PubMed ID: 24179162)
1. A novel discharge risk model for patients hospitalised for acute decompensated heart failure incorporating N-terminal pro-B-type natriuretic peptide levels: a European coLlaboration on Acute decompeNsated Heart Failure: ELAN-HF Score.
Salah K; Kok WE; Eurlings LW; Bettencourt P; Pimenta JM; Metra M; Bayes-Genis A; Verdiani V; Bettari L; Lazzarini V; Damman P; Tijssen JG; Pinto YM
Heart; 2014 Jan; 100(2):115-25. PubMed ID: 24179162
[TBL] [Abstract][Full Text] [Related]
2. N-terminal pro-B-type natriuretic peptide post-discharge monitoring in the management of patients with heart failure and preserved ejection fraction - a randomized trial: The NICE study.
Pascual-Figal DA; Hernández-Vicente A; Pastor-Pérez F; Martínez-Sellés M; Solé-González E; Alvarez-García J; García-Pavía P; Varela-Román A; Sánchez PL; Delgado JF; Noguera-Velasco JA; Bayes-Genis A;
Eur J Heart Fail; 2024 Apr; 26(4):776-784. PubMed ID: 38606524
[TBL] [Abstract][Full Text] [Related]
3. GDF-15: a novel biomarker of heart failure predicts short-term and long-term heart-failure rehospitalization and short-term mortality in patients with acute heart failure syndrome.
Kosum P; Siranart N; Mattanapojanat N; Phutinart S; Kongruttanachok N; Sinphurmsukskul S; Siwamogsatham S; Puwanant S; Ariyachaipanich A
BMC Cardiovasc Disord; 2024 Mar; 24(1):151. PubMed ID: 38475710
[TBL] [Abstract][Full Text] [Related]
4. Semaphorin 4D levels in heart failure patients: a potential novel biomarker of acute heart failure?
Willner N; Goldberg Y; Schiff E; Vadasz Z
ESC Heart Fail; 2018 Aug; 5(4):603-609. PubMed ID: 29524314
[TBL] [Abstract][Full Text] [Related]
5. Amino-Terminal Pro-B-Type Natriuretic Peptide for Diagnosis and Prognosis in Patients With Renal Dysfunction: A Systematic Review and Meta-Analysis.
Schaub JA; Coca SG; Moledina DG; Gentry M; Testani JM; Parikh CR
JACC Heart Fail; 2015 Dec; 3(12):977-89. PubMed ID: 26671676
[TBL] [Abstract][Full Text] [Related]
6. A prediction model for estimating NT-proBNP in a general Japanese population: the Toon Health Study.
Inoue K; Yamamoto K; Higashi H; Takata Y; Inaba S; Miyazaki S; Higaki A; Saito M; Osawa H; Yamaguchi O
ESC Heart Fail; 2024 Jun; 11(3):1483-1492. PubMed ID: 38303572
[TBL] [Abstract][Full Text] [Related]
7. N-Terminal Pro-Brain Type Natriuretic Peptide Predicts Cardiovascular Events Independently of Arterial Stiffness, Assessed By Carotid-to-Femoral Pulse Wave Velocity, in Apparently Healthy Subjects.
Frary CE; Blicher MK; Olesen TB; Pareek M; Vishram-Nielsen JKK; Rasmussen S; Olsen MH
Heart Lung Circ; 2024 Mar; 33(3):392-400. PubMed ID: 38290952
[TBL] [Abstract][Full Text] [Related]
8. NT-proBNP and Risk of Dementia in a General Japanese Elderly Population: The Hisayama Study.
Nagata T; Ohara T; Hata J; Sakata S; Furuta Y; Yoshida D; Honda T; Hirakawa Y; Ide T; Kanba S; Kitazono T; Tsutsui H; Ninomiya T
J Am Heart Assoc; 2019 Sep; 8(17):e011652. PubMed ID: 31446828
[TBL] [Abstract][Full Text] [Related]
9. Influence of atrial fibrillation on post-discharge natriuretic peptide trajectory and clinical outcomes among patients hospitalized for heart failure: insights from the ASTRONAUT trial.
Greene SJ; Fonarow GC; Solomon SD; Subacius HP; Ambrosy AP; Vaduganathan M; Maggioni AP; Böhm M; Lewis EF; Zannad F; Butler J; Gheorghiade M;
Eur J Heart Fail; 2017 Apr; 19(4):552-562. PubMed ID: 27748006
[TBL] [Abstract][Full Text] [Related]
10. Primary care REFerral for EchocaRdiogram (REFER) in heart failure: a diagnostic accuracy study.
Taylor CJ; Roalfe AK; Iles R; Hobbs FR; ; Barton P; Deeks J; McCahon D; Cowie MR; Sutton G; Davis RC; Mant J; McDonagh T; Tait L
Br J Gen Pract; 2017 Feb; 67(655):e94-e102. PubMed ID: 27919937
[TBL] [Abstract][Full Text] [Related]
11. Derivation and validation of a clinical predictive model of NT-proBNP ≥125 pg/mL to detect pre-heart failure.
Nogi K; Yamamoto R; Ueda T; Nogi M; Ishihara S; Nakada Y; Hashimoto Y; Nakagawa H; Nishida T; Seno A; Onoue K; Watanabe M; Takaya N; Masuda I; Saito Y
J Cardiol; 2023 Dec; 82(6):481-489. PubMed ID: 37247659
[TBL] [Abstract][Full Text] [Related]
12. NT-proBNP Qualifies as a Surrogate for Clinical End Points in Heart Failure.
Schmitt W; Rühs H; Burghaus R; Diedrich C; Duwal S; Eissing T; Garmann D; Meyer M; Ploeger B; Lippert J
Clin Pharmacol Ther; 2021 Aug; 110(2):498-507. PubMed ID: 33630302
[TBL] [Abstract][Full Text] [Related]
13. Inverse association of N-terminal pro-B-type natriuretic peptide with metabolic syndrome in patients with congestive heart failure.
Chang HR; Hsieh JC; Hsu BG; Wang LY; Chen MY; Wang JH
PLoS One; 2013; 8(11):e79096. PubMed ID: 24265747
[TBL] [Abstract][Full Text] [Related]
14. Dynamics in insulin resistance and plasma levels of adipokines in patients with acute decompensated and chronic stable heart failure.
Schulze PC; Biolo A; Gopal D; Shahzad K; Balog J; Fish M; Siwik D; Colucci WS
J Card Fail; 2011 Dec; 17(12):1004-11. PubMed ID: 22123363
[TBL] [Abstract][Full Text] [Related]
15. Implications of the ACC/AHA risk score for prediction of heart failure: the Rotterdam Study.
Arshi B; van den Berge JC; van Dijk B; Deckers JW; Ikram MA; Kavousi M
BMC Med; 2021 Feb; 19(1):43. PubMed ID: 33588853
[TBL] [Abstract][Full Text] [Related]
16. Development and validation of a decision support tool for the diagnosis of acute heart failure: systematic review, meta-analysis, and modelling study.
Lee KK; Doudesis D; Anwar M; Astengo F; Chenevier-Gobeaux C; Claessens YE; Wussler D; Kozhuharov N; Strebel I; Sabti Z; deFilippi C; Seliger S; Moe G; Fernando C; Bayes-Genis A; van Kimmenade RRJ; Pinto Y; Gaggin HK; Wiemer JC; Möckel M; Rutten JHW; van den Meiracker AH; Gargani L; Pugliese NR; Pemberton C; Ibrahim I; Gegenhuber A; Mueller T; Neumaier M; Behnes M; Akin I; Bombelli M; Grassi G; Nazerian P; Albano G; Bahrmann P; Newby DE; Japp AG; Tsanas A; Shah ASV; Richards AM; McMurray JJV; Mueller C; Januzzi JL; Mills NL;
BMJ; 2022 Jun; 377():e068424. PubMed ID: 35697365
[TBL] [Abstract][Full Text] [Related]
17. Deep learning-based NT-proBNP prediction from the ECG for risk assessment in the community.
Neyazi M; Bremer JP; Knorr MS; Gross S; Brederecke J; Schweingruber N; Csengeri D; Schrage B; Bahls M; Friedrich N; Zeller T; Felix S; Blankenberg S; Dörr M; Vollmer M; Schnabel RB
Clin Chem Lab Med; 2024 Mar; 62(4):740-752. PubMed ID: 37982681
[TBL] [Abstract][Full Text] [Related]
18. Associations Between New York Heart Association Classification, Objective Measures, and Long-term Prognosis in Mild Heart Failure: A Secondary Analysis of the PARADIGM-HF Trial.
Rohde LE; Zimerman A; Vaduganathan M; Claggett BL; Packer M; Desai AS; Zile M; Rouleau J; Swedberg K; Lefkowitz M; Shi V; McMurray JJV; Solomon SD
JAMA Cardiol; 2023 Feb; 8(2):150-158. PubMed ID: 36477809
[TBL] [Abstract][Full Text] [Related]
19. Dose of furosemide before admission predicts diuretic efficiency and long-term prognosis in acute heart failure.
Blázquez-Bermejo Z; Farré N; Caravaca Perez P; Llagostera M; Morán-Fernández L; Fort A; de Juan Bagudá J; García-Cosio MD; Ruiz-Bustillo S; Delgado JF
ESC Heart Fail; 2022 Feb; 9(1):656-666. PubMed ID: 34766460
[TBL] [Abstract][Full Text] [Related]
20. Urinary C-type natriuretic peptide: a new heart failure biomarker.
Zakeri R; Sangaralingham SJ; Sandberg SM; Heublein DM; Scott CG; Burnett JC
JACC Heart Fail; 2013 Apr; 1(2):170-7. PubMed ID: 24244916
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
